Ferritin overexpression for noninvasive magnetic resonance imaging-based tracking of stem cells transplanted into the heart

Molecular Imaging

Volumn 9, Issue 4, 2010, Pages 201-210

  Naumova, Anna V ^a   Reinecke, Hans ^a   Yarnykh, Vasily ^a   Deem, Jennifer ^a   Yuan, Chun ^a   Murry, Charles E ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C2C12 CELLS; CARDIAC CELL; CELL DYNAMICS; CELL VIABILITY; COMMONLY USED; GRAFT SIZES; HYPOINTENSITY; IN-VITRO; IN-VIVO; IRON ACCUMULATION; IRON-BINDING PROTEIN; MOUSE HEART; MULTINUCLEATED MYOTUBES; NON-INVASIVE IMAGING; OVER-EXPRESSION; SKELETAL MYOBLASTS; SUPERPARAMAGNETIC NANOPARTICLES; TRANSGENIC CELLS; TRANSGENIC GRAFTS; WILD-TYPE CELLS;

GRAFTING (CHEMICAL); GRAFTS; HEART; IRON COMPOUNDS; MAGNETIC RESONANCE IMAGING; RESONANCE; SUPERPARAMAGNETISM;

STEM CELLS;

APOFERRITIN; HYBRID PROTEIN;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL GROWTH; CELL LINE; CELL SURVIVAL; CYTOLOGY; GENETIC TRANSFECTION; GENETICS; HEART INFARCTION; HEART MUSCLE; METABOLISM; METHODOLOGY; MOUSE; MYOBLAST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PHYSIOLOGY; REPRODUCIBILITY; STATISTICAL MODEL; STEM CELL; STEM CELL TRANSPLANTATION;

ANIMALS; APOFERRITINS; CELL DIFFERENTIATION; CELL GROWTH PROCESSES; CELL LINE; CELL SURVIVAL; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MICE; MYOBLASTS, SKELETAL; MYOCARDIAL INFARCTION; MYOCARDIUM; RECOMBINANT FUSION PROTEINS; REPRODUCIBILITY OF RESULTS; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSFECTION;

EID: 77956490539     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2010.00020     Document Type: Article

References (32)

1. Laflamme MA, Zbinden S, Epstein SE, Murry CE. Cell-based therapy for myocardial ischemia and infarction: pathophysiological mechanisms. Annu Rev Pathol 2007;2:307-39.
2. Chien KR, Domian IJ, Parker KK. Cardiogenesis and the complex biology of regenerative cardiovascular medicine. Science 2008; 5;322(5907):149-7.
3. Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest 2005;115:572- 83.
4. Bulte JW, Kraitchman DL. Monitoring cell therapy using iron oxide MR contrast agents. Curr Pharm Biotechnol 2004;5:567-84.
5. Kraitchman DL, Tatsumi M, Gilson WD, et al. Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation 2005;112:1451-61.
6. Amsalem Y, Mardor Y, Feinberg MS, et al. Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium. Circulation 2007;116(11 Suppl):I38-5 .
7. Terrovitis J, Stuber M, Youssef A, et al. Magnetic resonance imaging overestimates ferumoxide-labeled stem cell survival after transplantation in the heart. Circulation 2008;117:1555-62.
8. Cohen B, Dafni H, Meir G, et al. Ferritin as an endogenous MRI reporter for noninvasive imaging of gene expression in C6 glioma tumors. Neoplasia 2005;7:109-17.
9. Genove G, De Marco U, Xu H, et al. A new transgene reporter for in vivo magnetic resonance imaging. Nat Med 2005;11:450-4.
10. Theil EC. Ferritin: structure, gene regulation, and cellular function in animals, plants, and microorganisms. Annu Rev Biochem 1987; 56:289-315.
11. Crichton RR, Wilmet S, Legssyer R, Ward RJ. Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells. J Inorg Biochem 2002;91:9-18.
12. Arosio P, Levi S. Ferritin, iron homeostasis, and oxidative damage. Free Radic Biol Med 2002;33:457-63.
13. Deans AE, Wadghiri YZ, Bemas LM, et al. Cellular MRI contrast via coexpression of transferrin receptor and ferritin. Magn Reson Med 2006;56:51-9.
14. Liu J, Cheng EC, Long Jr RC, et al. Noninvasive monitoring of embryonic stem cells in vivo with MRI transgene reporter. Tissue Eng Part C Methods 2009 Mar[Epub ahead of print].
15. Golob JL, Paige SL, Muskheli V, et al. Chromatin remodeling during mouse and human embryonic stem cell differentiation. Dev Dyn 2008;237:1389-8.
16. Silberstein L, Webster SG, Travis M, Blau HM. Developmental progression of myosin gene expression in cultured muscle cells. Cell 1986;46:1075-81.
17. Wang J, Yarnykh VL, Chu B, Yuan C. Improved motion-sensitized driven equilibrium (iMSDE) blood-suppression sequence for atherosclerosis plaque imaging at 3T. In: Proceedings of the 16th Annual Meeting of International Society for Magnetic Resonance in Medicine (ISMRM); 2008; Toronto. p 961.
18. Leobon B, Garcin I, Menasche P. Myoblasts transplanted into rat infracted myocardium are functionally isolated from their host. PNAS 2003;100:7808-11.
19. Reinecke H, MacDonald GH, Hauschka SD, Murry CE. Electromechanical coupling between skeletal and cardiac muscle. Implications for infarct repair. J Cell Biol 2000;149:731-40.
20. Reinlib L, Field L. Cell transplantation as future therapy for cardiovascular disease? A workshop of the National Heart, Lung, and Blood Institute. Circulation 2000;101: E182-7.
21. Robey TE, Murry CE. Absence of regeneration in the MRL/MpJ mouse heart following infarction or cryoinjury. Cardiovasc Pathol 2008;17:6-13.
22. van Laake LW, Passier R, Doevendans PA, Mummery CL. Human embryonic stem cell-derived cardiomyocytes and cardiac repair in rodents. Circ Res 2008;102:1008-10.
23. Robey TE, Saiget MK, Reinecke H, Murry CE. Systems approaches to preventing transplanted cell death in cardiac repair. J Mol Cell Cardiol 2008;45:567-81.
24. Laflamme MA, Chen KY, Naumova AV, et al. Delivery of human embryonic stem cell cardiomyocytes in pro-survival factors enhances the function of infarcted heARTs. Nat Biotech 2007;25:1015-24.
25. Cao F, Lin S, Xie X, et al. In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery. Circulation 2006;113:1005-14.
26. Meyer N, Jaconi M, Landopoulou A, et al. A fluorescent reporter gene as a marker for ventricular specification in ES-derived cardiac cells. FEBS Lett 2000;478:151-8.
27. Cozzi A, Corsi B, Levi S, et al. Overexpression of wild type and mutated human ferritin H-chain in HeLa cells: in vivo role of ferritin ferroxidase activity. J Biol Chem 2000;275: 25122-9.
28. Papanikolaou G, Pantopoulos K. Iron metabolism and toxicity. Toxicol Appl Pharmacol 2005;202:199-211.
29. Vymazal J, Brooks RA, Zak O, et al. T1 and T2 of ferritin at different field strengths: effect on MRI. Magn Reson Med 1992;27: 368-74.
30. Bulte JW, Vymazal J, Brooks RA, et al. Frequency dependence of MR relaxation times. II. Iron oxides. J Magn Reson Imaging 1993; 3:641-8.
31. Zurkiya O, Chan A, Hu X. MagA is sufficient for producing magnetic nanoparticles in mammalian cells, making it an MRI reporter. Magn Reson Med 2008;59:1225-31.
32. Goldhawk DE, Lemaire C, McCreary CR, et al. Magnetic resonance imaging of cells overexpressing MagA, an endogenous contrast agent for live cell imaging. Mol Imaging 2009;8: 129-39.